Health Care & Hospital Law,
Government
Feb. 12, 2020
Drug makers seek to block drug price reporting law
The Pharmaceutical Research and Manufacturers of America has filed a motion for summary judgment to block enforcement of SB 17, a 2017 drug price transparency law.
The Pharmaceutical Research and Manufacturers of America has filed a motion for summary judgment to block enforcement of SB 17, a 2017 drug price transparency law.
The law requires insurers and health plans to report drug prices, and the reason for any increase, to the state's rate review process. The goal of the bill was to help determine how much these costs contribute to the overall costs of health premiums. In September, the ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care & Hospital Law, Government, Constitutional Law, Civil Litigation
State drug price law doesn’t affect interstate commerce, judge rules
By Malcolm Maclachlan
